These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 19576682)
1. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. van Rhijn BW; Burger M; Lotan Y; Solsona E; Stief CG; Sylvester RJ; Witjes JA; Zlotta AR Eur Urol; 2009 Sep; 56(3):430-42. PubMed ID: 19576682 [TBL] [Abstract][Full Text] [Related]
2. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428 [TBL] [Abstract][Full Text] [Related]
3. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M; Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737 [TBL] [Abstract][Full Text] [Related]
4. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Babjuk M; Burger M; Compérat EM; Gontero P; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Zigeuner R; Capoun O; Cohen D; Escrig JLD; Hernández V; Peyronnet B; Seisen T; Soukup V Eur Urol; 2019 Nov; 76(5):639-657. PubMed ID: 31443960 [TBL] [Abstract][Full Text] [Related]
5. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Babjuk M; Oosterlinck W; Sylvester R; Kaasinen E; Böhle A; Palou-Redorta J; Rouprêt M; Eur Urol; 2011 Jun; 59(6):997-1008. PubMed ID: 21458150 [TBL] [Abstract][Full Text] [Related]
6. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience. Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376 [TBL] [Abstract][Full Text] [Related]
7. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Sylvester RJ; Oosterlinck W; Holmang S; Sydes MR; Birtle A; Gudjonsson S; De Nunzio C; Okamura K; Kaasinen E; Solsona E; Ali-El-Dein B; Tatar CA; Inman BA; N'Dow J; Oddens JR; Babjuk M Eur Urol; 2016 Feb; 69(2):231-44. PubMed ID: 26091833 [TBL] [Abstract][Full Text] [Related]
8. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer. Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637 [TBL] [Abstract][Full Text] [Related]
9. [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update]. Babjuk M; Oosterlinck W; Sylvester R; Kaasinen E; Böhle A; Palou-Redorta J; Rouprêt M; Actas Urol Esp; 2012; 36(7):389-402. PubMed ID: 22386115 [TBL] [Abstract][Full Text] [Related]
10. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin. Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115 [TBL] [Abstract][Full Text] [Related]
11. ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer. Monteiro LL; Witjes JA; Agarwal PK; Anderson CB; Bivalacqua TJ; Bochner BH; Boormans JL; Chang SS; Domínguez-Escrig JL; McKiernan JM; Dinney C; Godoy G; Kulkarni GS; Mariappan P; O'Donnell MA; Rentsch CA; Shah JB; Solsona E; Svatek RS; van der Heijden AG; van Valenberg FJP; Kassouf W World J Urol; 2019 Jan; 37(1):51-60. PubMed ID: 30109483 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum. Beijert IJ; Hentschel AE; Bründl J; Compérat EM; Plass K; Rodríguez O; Subiela Henríquez JD; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Mertens LS; Claps F; Masson-Lecomte A; Liedberg F; Cohen D; Lunelli L; Cussenot O; El Sheikh S; Volanis D; Côté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Ribal MJ; van der Kwast TH; Babjuk M; Sylvester RJ; van Rhijn BWG Eur Urol Oncol; 2023 Apr; 6(2):214-221. PubMed ID: 36670042 [TBL] [Abstract][Full Text] [Related]
13. Management of high-risk non-muscle invasive bladder cancer. Brausi M; Olaru V Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. Soukup V; Čapoun O; Cohen D; Hernández V; Babjuk M; Burger M; Compérat E; Gontero P; Lam T; MacLennan S; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Yuan Y; Zigeuner R Eur Urol; 2017 Nov; 72(5):801-813. PubMed ID: 28457661 [TBL] [Abstract][Full Text] [Related]
15. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey. Hendricksen K; Aziz A; Bes P; Chun FK; Dobruch J; Kluth LA; Gontero P; Necchi A; Noon AP; van Rhijn BWG; Rink M; Roghmann F; Rouprêt M; Seiler R; Shariat SF; Qvick B; Babjuk M; Xylinas E; Eur Urol Focus; 2019 Jul; 5(4):681-688. PubMed ID: 29074050 [TBL] [Abstract][Full Text] [Related]
16. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Cambier S; Sylvester RJ; Collette L; Gontero P; Brausi MA; van Andel G; Kirkels WJ; Silva FC; Oosterlinck W; Prescott S; Kirkali Z; Powell PH; de Reijke TM; Turkeri L; Collette S; Oddens J Eur Urol; 2016 Jan; 69(1):60-9. PubMed ID: 26210894 [TBL] [Abstract][Full Text] [Related]
17. Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre. Ali-El-Dein B; Sooriakumaran P; Trinh QD; Barakat TS; Nabeeh A; Ibrahiem el-HI BJU Int; 2013 Jun; 111(8):E331-41. PubMed ID: 23445082 [TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art]. Kausch von Schmeling I Aktuelle Urol; 2010 Sep; 41(5):307-15. PubMed ID: 20824576 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. van Rhijn BWG; Hentschel AE; Bründl J; Compérat EM; Hernández V; Čapoun O; Bruins HM; Cohen D; Rouprêt M; Shariat SF; Mostafid AH; Zigeuner R; Dominguez-Escrig JL; Burger M; Soukup V; Gontero P; Palou J; van der Kwast TH; Babjuk M; Sylvester RJ; Eur Urol Oncol; 2021 Apr; 4(2):182-191. PubMed ID: 33423944 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the Application of the Micrometric Substaging System to Predict Recurrence and Progression in a Cohort of Patients with pT1 High-Grade Non-Muscle Invasive Bladder Cancer. Lorusso V; Palmisano F; Piccinelli ML; Rossi RS; Lucignani G; Incarbone GP; Granata AM; Saredi G; Bozzini G; Gregori A Arch Esp Urol; 2024 Sep; 77(8):843-849. PubMed ID: 39385478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]